Lb Pharmaceuticals (LBRX) Other Non-Current Assets (2024 - 2026)

Lb Pharmaceuticals' Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $776000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $776000.0; the TTM figure through Mar 2026 stood at $776000.0 (changed N/A YoY), while the FY2025 annual figure was $770000.0, up 54.62% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $776000.0, up from $770000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $776000.0 in Q1 2026, with the low at $498000.0 in Q4 2024.
• The 3-year median for Other Non-Current Assets is $641000.0 (2025), against an average of $639000.0.
• Peak annual rise in Other Non-Current Assets reached 54.62% in 2025, while the deepest fall reached 54.62% in 2025.
• Lb Pharmaceuticals' Other Non-Current Assets stood at $498000.0 in 2024, then soared by 54.62% to $770000.0 in 2025, then increased by 0.78% to $776000.0 in 2026.
• Business Quant data shows LBRX's Other Non-Current Assets at $776000.0 in Q1 2026, $770000.0 in Q4 2025, and $512000.0 in Q3 2025.